{"id":"https://genegraph.clinicalgenome.org/r/aeebc6c2-b19b-446c-bc06-edc04cf70ce8v1.0","type":"EvidenceStrengthAssertion","dc:description":"*NAF1*, nuclear assembly factor 1 ribonucleoprotein, encodes a box H/ACA RNA biogenesis factor which  intervenes in early assembly steps of human box H/ACA RNPs, including telomerase (PMID: 16601202).\n*NAF1* was firstly reported in relation to pulmonary fibrosis in 2016 (Stanley et al., PMID: 27510903). The report described two frameshift mutations (K319Rfs*21 and S329Ifs*12 ) in two unrelated females with pulmonary fibrosis and bone marrow failure/ myelodysplasia. The reported variants were segregated with short telomere phenotype and low TR levels. An additional 11 (frameshift, splice site, inframe deletion and missense) variants were reported in the two retrospective cohort studies (Alder et al., (2021) PMID: 34933798 and Zhang et al., (2022) PMID: 36028256) that sequenced patients with Idiopathic Pulmonary Fibrosis (IPF) or IPF/Familial Pulmonary Fibrosis, respectively.\n\nExperimental evidence also supports this gene-disease relationship. Western blot of NAF1 in LCLs derived from mutation carriers detected a lower–molecular weight species similar to those detected by  Myc-tagging  NAF1 at an isogenic doxycycline-inducible locus in HeLa cells. Immunofluorescence showed a nuclear localization defect of NAF1 in the mutated cells (PMID: 27510903). *Naf1+/− *mice showed decreased TR levels, similar to *TR+/−* animals. Levels of H/ACA small nucleolar RNAs (snoRNAs) and a small Cajal body RNA were also reduced (PMID: 27510903).\n\nIn summary, *NAF1* is definitively associated with autosomal dominant pulmonary fibrosis and/or bone marrow failure, Telomere-related. This has been repeatedly demonstrated in both research and diagnostic settings and has been upheld over time.\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/aeebc6c2-b19b-446c-bc06-edc04cf70ce8","GCISnapshot":"https://genegraph.clinicalgenome.org/r/40f2a012-9098-4d27-9080-655ff76a1827","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/40f2a012-9098-4d27-9080-655ff76a1827_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10138","date":"2025-03-18T10:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/40f2a012-9098-4d27-9080-655ff76a1827_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10138","date":"2025-04-04T14:43:19.707Z","role":"Publisher"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/40f2a012-9098-4d27-9080-655ff76a1827_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0044532f-a334-41c9-b68b-7fa35f2bbf0e","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0044532f-a334-41c9-b68b-7fa35f2bbf0e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36028256","allele":{"id":"https://genegraph.clinicalgenome.org/r/1c1a8355-d6d3-453d-b31a-ebb6dcbd6f01","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_138386.3(NAF1):c.634+1G>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA358660836"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/be5a4c3b-5e23-4dd9-9bbf-2f6a3c52bbe5","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/be5a4c3b-5e23-4dd9-9bbf-2f6a3c52bbe5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34933798","allele":{"id":"https://genegraph.clinicalgenome.org/r/b2a41a14-8f04-40eb-a553-8577e6d00961","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_138386.3(NAF1):c.110del (p.Val37GlyfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA3044553754"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/19ca08a5-f562-4974-a7d7-35a1e98439d4","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/19ca08a5-f562-4974-a7d7-35a1e98439d4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34933798","allele":{"id":"https://genegraph.clinicalgenome.org/r/cff2f864-6f43-4368-814e-e4950efabbc3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_138386.3(NAF1):c.157G>T (p.Ala53Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA3126469"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/bbb97470-19c7-42bb-bdac-9bb6abfce0f3","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bbb97470-19c7-42bb-bdac-9bb6abfce0f3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34933798","allele":{"id":"https://genegraph.clinicalgenome.org/r/08302a27-2b39-419c-a920-3b988c2d4536","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_138386.3(NAF1):c.1415del (p.Pro472LeufsTer25)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA556454526"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/388c6268-3363-442c-9de5-f11a02a42808","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/388c6268-3363-442c-9de5-f11a02a42808_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36028256","allele":{"id":"https://genegraph.clinicalgenome.org/r/5580a612-7a5a-4757-8310-82e54dff7064","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_138386.3(NAF1):c.1123C>T (p.Arg375Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA358663286"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/809f5ed6-48ae-41f9-be3c-2ba699b97e39","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/809f5ed6-48ae-41f9-be3c-2ba699b97e39_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34933798","allele":{"id":"https://genegraph.clinicalgenome.org/r/f434591c-7d78-48c3-aad3-b18d6a20e170","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_138386.3(NAF1):c.889_891dup (p.Ser297dup)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1509008376"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/8a272cbc-6c48-4fd2-b740-f237f0462f7c","type":"EvidenceLine","dc:description":"The variant is a heterozygous single base pair (bp) insertion in exon 7 of NAF1, c.984insA, which predicted a premature stop after a short, out-of-frame amino acid sequence, S329Ifs*12, reported in 4 affected members of a 2-generation family. The proband scored has pulmonary fibrosis and myelodysplasia. The variant is present in the proband’s two siblings who had short telomere phenotypes.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8a272cbc-6c48-4fd2-b740-f237f0462f7c_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional defect is demonstrated by knocking in the mutation in pseudodiploid HCT116 cells. \nThe clone exhibited significantly decreased TR levels. Restoring full-length NAF1 by lentiviral complementary DNA (cDNA) transduction partially rescued TR, consistent with a NAF1-dependent effect on telomerase levels in these cells \n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/8a272cbc-6c48-4fd2-b740-f237f0462f7c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27510903","allele":{"id":"https://genegraph.clinicalgenome.org/r/be1c6628-a315-439b-a802-0302de348e47","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_138386.3(NAF1):c.984dup (p.Ser329IlefsTer12)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA3126200"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/9e39933b-8f09-4c05-add7-f03fef5d582d","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9e39933b-8f09-4c05-add7-f03fef5d582d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34933798","allele":{"id":"https://genegraph.clinicalgenome.org/r/1d7981af-fde8-4d8a-be0b-b9df2d373351","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_138386.3(NAF1):c.104C>T (p.Ala35Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA358661950"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/08b3238d-246a-4f3e-bbf1-88c4b549e686","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/08b3238d-246a-4f3e-bbf1-88c4b549e686_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34933798","allele":{"id":"https://genegraph.clinicalgenome.org/r/eb2a89a7-2bec-4b3c-9f0b-8238866426cb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_138386.3(NAF1):c.1407_1421del (p.Pro472_Pro476del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA3044553753"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/15b65ee8-795a-42bb-88e5-054e6fc0a27d","type":"EvidenceLine","dc:description":"The variant detected is a heterozygous 2-bp deletion  in exon 7 of the NAF1 gene, resulting in a frameshift and premature termination (Lys319ArgfsTer21) in a patient with pulmonary fibrosis, bone marrow failure and abnormally short telomere. The variant has functional evidence and is not reported in gnomAD.\n","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/15b65ee8-795a-42bb-88e5-054e6fc0a27d_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Western blot for Myc-tagged NAF1 at an isogenic doxycycline-inducible locus in HeLa cells shows shortened NAF1 proteins that migrated at a molecular weight similar to the truncated species observed in patient-derived cells\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/15b65ee8-795a-42bb-88e5-054e6fc0a27d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27510903","allele":{"id":"https://genegraph.clinicalgenome.org/r/6eef6f38-37a5-4c1f-8b31-aa2306fdd91e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_138386.3(NAF1):c.956_957del (p.Lys319ArgfsTer21)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2580613485"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/2592abf4-7b98-4c62-9c4a-8e0d230bc03c","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2592abf4-7b98-4c62-9c4a-8e0d230bc03c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36028256","allele":{"id":"https://genegraph.clinicalgenome.org/r/1043edca-235f-4239-b47c-93d805bbdd02","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_138386.3(NAF1):c.701G>C (p.Arg234Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA358660676"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/cb4dafdb-16d0-43f4-9a76-aef429cd4010","type":"EvidenceLine","dc:description":"Inframe deletion detected in heterzygous state in a pulmonary fibrosis patient included in a retrospective cohort study. ","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cb4dafdb-16d0-43f4-9a76-aef429cd4010_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36028256","allele":{"id":"https://genegraph.clinicalgenome.org/r/0586c1ef-16ea-432e-9a4a-a895fe0a5004","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_138386.3(NAF1):c.423_425del (p.Ser145del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA3126365"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/9271c99f-591a-47b4-8080-b4b5ecfd1098","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9271c99f-591a-47b4-8080-b4b5ecfd1098_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36028256","allele":{"id":"https://genegraph.clinicalgenome.org/r/127e867d-16b6-41d1-94fc-8bc6f916c930","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000004.12:g.163127017dup","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA556381670"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/40f2a012-9098-4d27-9080-655ff76a1827_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/40f2a012-9098-4d27-9080-655ff76a1827_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a2b3e73a-b953-4cbf-a45f-b904e86f13c7","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bcca3200-28cc-4da9-8bb6-f43ccf2fa070","type":"Finding","dc:description":"As with the human mutation carriers, TR levels in Naf1+/− mice were decreased","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27510903","rdfs:label":"Naf1+/− mice phenotype","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/33f2c3a3-7c82-4045-9c4e-848c1e7cba70","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ecca6cc0-f4f7-4cfb-9b76-9bf6e96f9973","type":"Finding","dc:description":"NAF1K319 could not rescue TR levels after shRNA knockdown, suggesting that the Gar1 homology domain altered in this mutant protein is required for TR stability which might explain the abnormally short telomeres seen in NAF1 mutant patients.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27510903","rdfs:label":"NAF1 mutations impair nuclear localization and TR stability","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityCellCultureModelOrganismCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":3}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":3}],"evidenceStrength":"Definitive","sequence":10173,"specifiedBy":"GeneValidityCriteria11","strengthScore":15,"subject":{"id":"https://genegraph.clinicalgenome.org/r/EyLJJElOAPA","type":"GeneValidityProposition","disease":"obo:MONDO_0957261","gene":"hgnc:25126","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_40f2a012-9098-4d27-9080-655ff76a1827-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}